In the onset of the COVID-19 pandemic, Corbett begun working on a vaccine to shield folks from coronavirus disorder.[3] Recognizing that the virus was similar to severe acute respiratory syndrome coronavirus, Corbett's team utilized previous familiarity with optimum coronavirus proteins to deal with COVID-19.[21][22] S proteins sort a "crown" withi